Back

The FAAH inhibitor URB597 reduces cocaine seeking during conditioned punishment and withdrawal

Alegre-Zurano, L.; Garcia-Baos, A.; Castro-Zavala, A.; Martin-Sanchez, A.; Medrano, M.; Gallego-Landin, I.; Valverde, O.

2023-03-13 neuroscience
10.1101/2023.03.13.532386 bioRxiv
Show abstract

The endocannabinoid system is prominently implicated in the control of cocaine reinforcement due to its relevant role in synaptic plasticity and neurotransmitter modulation in the mesocorticolimbic system. The inhibition of fatty acid amide hydrolase (FAAH), and the resulting increase in anandamide and other N-acylethanolamines, represents a promising strategy for reducing drug seeking. In the present study, we aimed to assess the effects of the FAAH inhibitor URB597 (1 mg/kg) on crucial features of cocaine addictive-like behaviour in mice. Therefore, we tested the effects of URB597 on acquisition of cocaine (0.6 mg/kg/inf) self-administration, compulsive-like cocaine intake and cue-induced drug-seeking behaviour during withdrawal. URB597 reduced cocaine intake under conditioned punishment while having no impact on acquisition. This result was associated to increased cannabinoid receptor 1 gene expression in the ventral striatum and medium spiny neurons activation in the nucleus accumbens shell. Moreover, URB597 reduced cue-induced drug-seeking behaviour during prolonged abstinence and prevented the withdrawal-induced increase in FAAH gene expression in the ventral striatum. In this case, URB597 decreased activation of medium spiny neurons in the nucleus accumbens core. Our findings evidence the prominent role of endocannabinoids in the development of cocaine addictive-like behaviours and support the potential of FAAH inhibition as a therapeutical target for the treatment of cocaine addiction.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Addiction Biology
47 papers in training set
Top 0.1%
32.0%
2
Neuropharmacology
60 papers in training set
Top 0.1%
9.8%
3
Psychopharmacology
59 papers in training set
Top 0.1%
6.2%
4
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
6.1%
50% of probability mass above
5
Neuropsychopharmacology
134 papers in training set
Top 0.7%
4.2%
6
Scientific Reports
3102 papers in training set
Top 32%
3.9%
7
Translational Psychiatry
219 papers in training set
Top 2%
3.5%
8
Addiction Neuroscience
17 papers in training set
Top 0.2%
3.5%
9
International Journal of Molecular Sciences
453 papers in training set
Top 3%
3.2%
10
Brain Sciences
52 papers in training set
Top 0.3%
2.3%
11
Behavioural Brain Research
70 papers in training set
Top 0.4%
1.8%
12
Neuroscience
88 papers in training set
Top 0.9%
1.8%
13
eneuro
389 papers in training set
Top 6%
1.6%
14
British Journal of Pharmacology
34 papers in training set
Top 0.3%
1.4%
15
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.6%
1.3%
16
Journal of Psychopharmacology
14 papers in training set
Top 0.4%
1.2%
17
PLOS ONE
4510 papers in training set
Top 63%
0.9%
18
Molecular Psychiatry
242 papers in training set
Top 3%
0.9%
19
Alcohol
15 papers in training set
Top 0.3%
0.7%
20
Frontiers in Pharmacology
100 papers in training set
Top 6%
0.6%
21
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.4%
0.6%